The potency of acyclovir can be markedly different in different cell types

Area of Science:

• Virology
• Pharmacology
• Cell Biology

Background:

• Acyclovir is an acyclic guanine analog with known activity against herpes simplex viruses (HSV).
• Understanding the differential activity of antiviral drugs in various cell types is crucial for optimizing treatment strategies.

Purpose of the Study:

• To investigate the antiherpetic activity and cytotoxicity of acyclovir in macrophage and fibroblast cell lines.
• To compare the efficacy of acyclovir against HSV-1 in macrophages versus fibroblast cells.
• To explore potential mechanisms behind observed differences in antiviral activity.

Main Methods:

• Utilized a plaque reduction assay to quantify HSV-1 inhibition.
• Assessed acyclovir's efficacy (EC50) and cytotoxicity in macrophages, Vero cells, and MRC-5 cells.
• Compared acyclovir's activity with Foscarnet and PMEA in the studied cell lines.

Main Results:

• Acyclovir potently inhibited HSV-1 replication in macrophages (EC50 = 0.0025 microM) compared to Vero (EC50 = 8.5 microM) and MRC-5 (EC50 = 3.3 microM) cells.
• No cytotoxicity of acyclovir was detected at concentrations less than or equal to 20 microM, resulting in a selective index greater than 8000 in macrophages.
• This marked difference in antiherpetic activity between macrophages and fibroblasts was not observed with Foscarnet and PMEA.

Conclusions:

• Macrophages exhibit significantly higher sensitivity to acyclovir's antiherpetic effects compared to fibroblast cell lines.
• The potent antiviral effect in macrophages is suggested to be due to proficient drug phosphorylation and/or a favorable dGTP/acyclovir triphosphate ratio.
• Acyclovir's differential activity warrants further investigation for targeted antiviral therapies.